Optimal Itch Response in Adults Treated with Dupilumab for Moderate-to-Severe Atopic Dermatitis

Article full text The above Graphical Abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).